Status:

UNKNOWN

Evaluation of the Brain Natriuretic Peptide as a Predictor of Morbidity and Mortality in Cardiac Surgery

Lead Sponsor:

University Hospital, Strasbourg, France

Conditions:

Coronary Artery Disease

Valvular Disease

Eligibility:

All Genders

18+ years

Brief Summary

Objective: The purpose of the present study is to assess if perioperative variation of Brain Natriuretic Peptide (BNP) levels is a predictor of mortality and morbidity after cardiac surgery.Material a...

Eligibility Criteria

Inclusion

  • Patient who need cardiac surgery
  • Age \> 18 years

Exclusion

  • Patient on mechanic ventilation before surgery
  • Aortic dissection-Congenital disease

Key Trial Info

Start Date :

June 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2017

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT00699673

Start Date

June 1 2008

End Date

June 1 2017

Last Update

August 7 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Service de Chirurgie Cardio-Vasculaire au NHC, Hôpitaux Universitaires de Strasbourg

Strasbourg, France, 67 091

Evaluation of the Brain Natriuretic Peptide as a Predictor of Morbidity and Mortality in Cardiac Surgery | DecenTrialz